Hiroyuki Oshiumi

Kumamoto, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications

Position-5-Driven Reorientation of an Immunodominant HLA-A*24:02 SARS-CoV-2 Epitope Drives Universal T-cell Escape.

Position-5-Driven Reorientation of an Immunodominant HLA-A*24:02 SARS-CoV-2 Epitope Drives Universal T-cell Escape.

Journal: JCI insight
Published: March 17, 2026

Therapeutic Efficacy of the Supersulfide Donor NAC-S2 in Influenza Virus Pneumonia via Suppression of Excessive Inflammatory Responses.

Therapeutic Efficacy of the Supersulfide Donor NAC-S2 in Influenza Virus Pneumonia via Suppression of Excessive Inflammatory Responses.

Journal: Microbiology and immunology
Published: November 19, 2025

Position-5-driven reorientation of an immunodominant HLA-A*24:02 SARS-CoV-2 epitope drives universal T cell escape.

Position-5-driven reorientation of an immunodominant HLA-A*24:02 SARS-CoV-2 epitope drives universal T cell escape.

Journal: JCI insight
Published: November 13, 2025

The nucleolar protein NOP16 suppresses TGF-β-regulated IgA class switch recombination in B cells by regulating AID induction.

The nucleolar protein NOP16 suppresses TGF-β-regulated IgA class switch recombination in B cells by regulating AID induction.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 11, 2025

Molecular mechanism of MDA5 nucleation and filament formation by LGP2.

Molecular mechanism of MDA5 nucleation and filament formation by LGP2.

Journal: Molecular cell
Published: May 11, 2025

Lipid nanoparticle-encapsulated microRNA-192: An anti-inflammatory adjuvant that enhances vaccine efficacy in aged mice.

Lipid nanoparticle-encapsulated microRNA-192: An anti-inflammatory adjuvant that enhances vaccine efficacy in aged mice.

Journal: Molecular therapy. Nucleic acids
Published: May 10, 2025

ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction.

ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction.

Journal: Journal of virology
Published: April 15, 2025

Harnessing an integrated glyco-nanovaccine technology for enhanced cancer immunotherapy.

Harnessing an integrated glyco-nanovaccine technology for enhanced cancer immunotherapy.

Journal: Communications medicine
Published: July 03, 2024

Cholesterol restriction primes antiviral innate immunity via SREBP1-driven noncanonical type I IFNs.

Cholesterol restriction primes antiviral innate immunity via SREBP1-driven noncanonical type I IFNs.

Journal: EMBO reports
Published: May 22, 2024

Regulation of IL-17A-mediated hypersensitivity by extracellular vesicles and lipid nanoparticles carrying miR-451a.

Regulation of IL-17A-mediated hypersensitivity by extracellular vesicles and lipid nanoparticles carrying miR-451a.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 29, 2024

Development of a single-chain variable antibody fragment against a conserved region of the SARS-CoV-2 spike protein.

Development of a single-chain variable antibody fragment against a conserved region of the SARS-CoV-2 spike protein.

Journal: Scientific reports
Published: November 24, 2023

HPV vaccines induce trained immunity and modulate pro-inflammatory cytokine expression in response to secondary Toll-like receptor stimulations.

HPV vaccines induce trained immunity and modulate pro-inflammatory cytokine expression in response to secondary Toll-like receptor stimulations.

Journal: Microbiology and immunology
Published: August 09, 2023
Showing 1-12 of 94

Last Updated: 09/26/2026